An alliance of people united by a common vision

An alliance of people united by a common vision

Our vision is to be at the forefront of clinical science that improves prevention, diagnosis and treatment of infection in children

Our mission is to build a global network that conducts excellent research to help health systems achieve optimal outcomes for children


We support research that seeks to better understand both the dynamics of transmission and how to get optimal health outcomes for pregnant women and children  

Our scientific priorities are:

  • HIV & viral infection
  • Severe sepsis and antimicrobial resistance
  • Infection in pregnancy  
  • Neglected or emerging childhood infection


Our objectives

  • To create a vibrant network of experts and investigators generating solutions for children’s health, notably infections
  • To develop impactful research on prevention, diagnosis and treatment of infections in children
  • To deliver training and education for clinical providers and researchers that ensures high quality of care and research
  • To form partnerships that collaborate to drive research agendas and deliver impact
  • To facilitate a healthy pipeline of young investigators and inspire a new generation of leading researchers in paediatric infectious diseases

The Penta ID Network is central to everything we do at Penta.


Utilizing the skills, experience and expertise of all our Network members, the Penta Foundation, Penta Foundation UK and Penta ID Innovation develops and delivers world class research and training to drive understanding and practice related to infections in children.

Our history

The Penta network was established in 1991 as a collaboration between paediatric HIV centres in Europe. The primary aim of the network was to undertake independent clinical trials to address questions about antiretroviral therapies in HIV infected children, where answers could not be extrapolated from trials in adults.

To support the Penta ID Network, the Penta Foundation was set up in 2004, to act as the coordinating centre of research activities on HIV in children.

Over time, we have evolved, and in 2011 the network officially became Penta ID (Infectious Diseases), extending our research to other paediatric infectious diseases. The Penta ID Network has steadily grown since its initiation in Europe and now spans over 100 clinical sites in 31 countries, including clinical sites and collaborators in Asia, Africa and the Americas.

In 2016, a spin off company (Penta ID Innovation) was set up by the Foundation in order to provide services to companies and invest directly in specific projects. Penta ID Innovation is a global site management organisation, which utilises the Penta ID Network capabilities, to close the gap between industry and academia to deliver high quality consultancy services to paediatric infectious disease research.

In 2019, the Penta Foundation registered in the UK as a charity. This allows Penta to apply for UK funding for paediatric infectious disease research.

Today, Penta is a multifaceted network of scientists and professionals involved in several areas of paediatric infectious diseases.

We are researchers, trial methodologists and statisticians. Through robust scientific evidence reported in hundreds of publications, we have made significant contributions to improving the understanding of paediatric infectious diseases, the dynamics of viral transmission and the optimization of evidence-based treatments.

We are clinicians from all over the world, included low and middle-income countries where the burden of diseases is greatest. We bring to Penta our knowledge and the experience we have been gaining each day in our efforts to save lives and protect children and their families from preventable diseases in our little patients and understanding the burden of antimicrobial resistance.

We are social workers. Working on the front line to tackle stigma associated with HIV and the psychological problems and the social challenges that can hinder adherence to treatment. We are committed to engaging young people in the design and development of clinical trials in a meaningful way – because nothing is more important than their emotional wellbeing. As peer mentors, they help us raise social and health awareness in their communities.

Our research programs and public and private partnerships make us a leading children’s health organization whose aim is to conduct high-quality research to help health systems achieve optimal outcomes for children.


We would like to update you on our recent activities